Examining Real-World Evidence on Latest Therapies for Retinal Disease
Nikolas JS London, MD, FACS presents two cases, one with a 92-year-old woman with a long history of bilateral nAMD, and one with a 70-year-old man with IDDM.
EP. 1: A case of longstanding bilateral neovascular AMD
September 30th 2024Dr. London examines a case of longstanding bilateral neovascular age-related macular degeneration (AMD), focusing on the patient's clinical history, treatment challenges, and the potential impact of recent therapeutic advancements on management strategies.
EP. 2: Perspectives on Latest Therapies: Faricimab and Aflibercept 8mg
September 30th 2024Dr. London discusses the implications of faricimab and aflibercept 8 mg in treating retinal diseases, highlighting their mechanisms, efficacy data, and potential to enhance patient outcomes in conditions like wet age-related macular degeneration.
EP. 3: A case of DME with persistent subretinal fluid
September 30th 2024Dr. London discusses a case of diabetic macular edema (DME) with persistent subretinal fluid, emphasizing the diagnostic considerations, treatment options, and the implications for patient outcomes in the context of evolving therapeutic approaches.
